128 related articles for article (PubMed ID: 38401258)
21. MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
Ghai S; Finelli A; Corr K; Chan R; Jokhu S; Li X; McCluskey S; Konukhova A; Hlasny E; van der Kwast TH; Incze PF; Zlotta AR; Hamilton RJ; Haider MA; Kucharczyk W; Perlis N
Radiology; 2021 Mar; 298(3):695-703. PubMed ID: 33529137
[TBL] [Abstract][Full Text] [Related]
22. High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.
Dason S; Wong NC; Allard CB; Hoogenes J; Orovan W; Shayegan B
Int Braz J Urol; 2018; 44(2):248-257. PubMed ID: 29211405
[TBL] [Abstract][Full Text] [Related]
23. A Multicenter, Randomized, Single-blind, 2-Arm Intervention Study Evaluating the Adverse Events and Quality of Life After Irreversible Electroporation for the Ablation of Localized Low-intermediate Risk Prostate Cancer.
de la Rosette J; Dominguez-Escrig J; Zhang K; Teoh J; Barret E; Ramon-Borja JC; Muir G; Bohr J; de Reijke T; Ng CF; Leung CH; Sanchez-Salas R; Laguna P
J Urol; 2023 Feb; 209(2):347-353. PubMed ID: 36441776
[TBL] [Abstract][Full Text] [Related]
24. [HIFU therapy of localized prostate cancer using image-guided robotic HIFU Focal One].
Govorov AV; Vasilyev AO; Alaverdyan AI; Kolontarev KB; Pushkar DY
Urologiia; 2023 May; (2):83-89. PubMed ID: 37401710
[TBL] [Abstract][Full Text] [Related]
25. High-intensity focused ultrasound with visually directed power adjustment for focal treatment of localized prostate cancer: systematic review and meta-analysis.
Peretsman SJ; Emberton M; Fleshner N; Shoji S; Bahler CD; Miller LE
World J Urol; 2024 Mar; 42(1):175. PubMed ID: 38507093
[TBL] [Abstract][Full Text] [Related]
26. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients.
Rischmann P; Gelet A; Riche B; Villers A; Pasticier G; Bondil P; Jung JL; Bugel H; Petit J; Toledano H; Mallick S; Rouvière O; Rabilloud M; Tonoli-Catez H; Crouzet S
Eur Urol; 2017 Feb; 71(2):267-273. PubMed ID: 27720531
[TBL] [Abstract][Full Text] [Related]
27. Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected.
Duwe G; Boehm K; Haack M; Sparwasser P; Brandt MP; Mager R; Tsaur I; Haferkamp A; Höfner T
World J Urol; 2023 May; 41(5):1293-1299. PubMed ID: 36920492
[TBL] [Abstract][Full Text] [Related]
28. New treatments for localized prostate cancer.
Marberger M; Carroll PR; Zelefsky MJ; Coleman JA; Hricak H; Scardino PT; Abenhaim LL
Urology; 2008 Dec; 72(6 Suppl):S36-43. PubMed ID: 19095127
[TBL] [Abstract][Full Text] [Related]
29. An Exploratory Study of Dose Escalation
Huber PM; Afzal N; Arya M; Boxler S; Dudderidge T; Emberton M; Guillaumier S; Hindley RG; Hosking-Jervis F; Leemann L; Lewi H; McCartan N; Moore CM; Nigam R; Odgen C; Persad R; Thalmann GN; Virdi J; Winkler M; Ahmed HU
J Endourol; 2020 Jun; 34(6):641-646. PubMed ID: 32253928
[No Abstract] [Full Text] [Related]
30. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prostate Cancer.
Khandwala YS; Soerensen SJC; Morisetty S; Ghanouni P; Fan RE; Vesal S; Rusu M; Sonn GA
Eur Urol Focus; 2023 Jul; 9(4):584-591. PubMed ID: 36372735
[TBL] [Abstract][Full Text] [Related]
31. First experiences using transurethral ultrasound ablation (TULSA) as a promising focal approach to treat localized prostate cancer: a monocentric study.
Peters I; Hensen B; Glandorf J; Gutberlet M; Dohna M; Struckmann S; Kuczyk MA; Wacker F; Hellms S
BMC Urol; 2023 Aug; 23(1):142. PubMed ID: 37644453
[TBL] [Abstract][Full Text] [Related]
32. Quality of life following high-intensity focused ultrasound for the treatment of localized prostate cancer: a prospective study.
Shoji S; Nakano M; Nagata Y; Usui Y; Terachi T; Uchida T
Int J Urol; 2010 Aug; 17(8):715-9. PubMed ID: 20529139
[TBL] [Abstract][Full Text] [Related]
33. Focal Therapy for Prostate Cancer with In-Bore MR-guided Focused Ultrasound: Two-Year Follow-up of a Phase I Trial-Complications and Functional Outcomes.
Tay KJ; Cheng CWS; Lau WKO; Khoo J; Thng CH; Kwek JW
Radiology; 2017 Nov; 285(2):620-628. PubMed ID: 28654336
[TBL] [Abstract][Full Text] [Related]
34. A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer: A systematic review.
Faure Walker NA; Norris JM; Shah TT; Yap T; Cathcart P; Moore CM; Ahmed HU; Emberton M; Minhas S
Urol Oncol; 2018 Feb; 36(2):67-76. PubMed ID: 29277585
[TBL] [Abstract][Full Text] [Related]
35. Focal cryosurgical ablation of the prostate: a single institute's perspective.
Hale Z; Miyake M; Palacios DA; Rosser CJ
BMC Urol; 2013 Jan; 13():2. PubMed ID: 23311921
[TBL] [Abstract][Full Text] [Related]
36. Comparing High-Intensity Focal Ultrasound Hemiablation to Robotic Radical Prostatectomy in the Management of Unilateral Prostate Cancer: A Matched-Pair Analysis.
Albisinni S; Aoun F; Bellucci S; Biaou I; Limani K; Hawaux E; Peltier A; van Velthoven R
J Endourol; 2017 Jan; 31(1):14-19. PubMed ID: 27799004
[TBL] [Abstract][Full Text] [Related]
37. Does mpMRI guidance improve HIFU partial gland ablation compared to conventional ultrasound guidance? Early functional outcomes and complications from a single center.
Sivaraman A; Marra G; Stabile A; Mombet A; Macek P; Lanz C; Cathala N; Moschini M; Carneiro A; Sanchez-Salas R; Cathelineau X
Int Braz J Urol; 2020; 46(6):984-992. PubMed ID: 32822127
[TBL] [Abstract][Full Text] [Related]
38. Oncological and functional outcome after partial prostate HIFU ablation with Focal-One
Dellabella M; Branchi A; Di Rosa M; Pucci M; Gasparri L; Claudini R; Carnevali F; Cecchini S; Castellani D
Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1189-1197. PubMed ID: 34007021
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of functional and oncological outcomes of localized prostate cancer after different minimally invasive therapeutic methods: A single center experience.
Chinenov DV; Shpot EV; Chernov YN; Gerasimov AN; Kazachevskaya LY; Lyapichev KA; Ismailov HM; Tsukkiev ZK; Korolev DO; Rapoport LM
Urologia; 2024 May; 91(2):311-319. PubMed ID: 38247121
[TBL] [Abstract][Full Text] [Related]
40. Significant Impact of the Anterior Transition Zone Portion Treatment on Urinary Function After Focal Therapy with High-Intensity Focused Ultrasound for Prostate Cancer.
Hanada I; Shoji S; Takeda K; Uchida T; Yuzuriha S; Kuroda S; Ogawa T; Higure T; Nakano M; Kawakami M; Nitta M; Hasegawa M; Kawamura Y; Miyajima A
J Endourol; 2021 Jul; 35(7):951-960. PubMed ID: 33499743
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]